{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:32:32Z","timestamp":1768739552874,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00134-014-3376-7","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T14:26:29Z","timestamp":1404397589000},"page":"1553-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["What is new in the use of aminoglycosides in critically ill patients?"],"prefix":"10.1007","volume":"40","author":[{"given":"Dimitrios K.","family":"Matthaiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"key":"3376_CR1","unstructured":"De Waele J, De Neve N (2013) Aminoglycosides for life-threatening infections: a plea for an individualized approach using intensive therapeutic drug monitoring. Minerva Anestesiologica [Epub ahead of print]"},{"key":"3376_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","volume":"37","author":"JA Roberts","year":"2009","unstructured":"Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37:840\u2013851 (quiz 859)","journal-title":"Crit Care Med"},{"key":"3376_CR3","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc8945","volume":"14","author":"FS Taccone","year":"2010","unstructured":"Taccone FS, Laterre PF, Spapen H, Dugernier T, Delattre I, Layeux B, De Backer D, Wittebole X, Wallemacq P, Vincent JL, Jacobs F (2010) Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care 14:R53","journal-title":"Crit Care"},{"key":"3376_CR4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1469-0691.2009.03074.x","volume":"16","author":"J Goncalves-Pereira","year":"2010","unstructured":"Goncalves-Pereira J, Martins A, Povoa P (2010) Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose. Clin Microbiol Infect 16:1258\u20131263","journal-title":"Clin Microbiol Infect"},{"key":"3376_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","volume":"25","author":"PD Tamma","year":"2012","unstructured":"Tamma PD, Cosgrove SE, Maragakis LL (2012) Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev 25:450\u2013470","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"3376_CR6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00134-014-3276-x","volume":"40","author":"E Montmollin de","year":"2014","unstructured":"de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R (2014) Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25\u00a0mg\/kg total body weight regimen. Intensive Care Med 40(7):998\u20131005. doi: 10.1007\/s00134-014-3276-x","journal-title":"Intensive Care Med"},{"key":"3376_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijantimicag.2013.04.021","volume":"42","author":"H Zazo","year":"2013","unstructured":"Zazo H, Martin-Suarez A, Lanao JM (2013) Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic\/pharmacodynamic analysis using Monte Carlo simulation. Int J Antimicrob Agents 42:155\u2013160","journal-title":"Int J Antimicrob Agents"},{"key":"3376_CR8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00134-013-2909-9","volume":"39","author":"Y Shimamoto","year":"2013","unstructured":"Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D (2013) Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med 39:1247\u20131252","journal-title":"Intensive Care Med"},{"key":"3376_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2050-6511-13-14","volume":"13","author":"DM D\u2019Arcy","year":"2012","unstructured":"D\u2019Arcy DM, Casey E, Gowing CM, Donnelly MB, Corrigan OI (2012) An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration. BMC Pharmacol Toxicol 13:14","journal-title":"BMC Pharmacol Toxicol"},{"key":"3376_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/1120009X12Z.0000000006","volume":"24","author":"N Petejova","year":"2012","unstructured":"Petejova N, Zahalkova J, Duricova J, Kacirova I, Brozmanova H, Urbanek K, Grundmann M, Martinek A (2012) Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients. J Chemother 24:107\u2013112","journal-title":"J Chemother"},{"key":"3376_CR11","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/cc12853","volume":"17","author":"M Rocco","year":"2013","unstructured":"Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Gennaro P, Raponi G, Vitale M, Pietropaoli P, Antonelli M (2013) Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and\/or other nephrotoxic antibiotics: a retrospective cohort study. Crit Care 17:R174","journal-title":"Crit Care"},{"key":"3376_CR12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","volume":"78","author":"HS Sader","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN (2014) Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011). Diagn Microbiol Infect Dis 78:443\u2013448","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3376_CR13","doi-asserted-by":"crossref","first-page":"O117","DOI":"10.1111\/1469-0691.12341","volume":"20","author":"F Kontopidou","year":"2014","unstructured":"Kontopidou F, Giamarellou H, Katerelos P, Maragos A, Kioumis I, Trikka-Graphakos E, Valakis C, Maltezou HC (2014) Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 20:O117\u2013O123","journal-title":"Clin Microbiol Infect"},{"key":"3376_CR14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00134-013-2872-5","volume":"39","author":"S Ehrmann","year":"2013","unstructured":"Ehrmann S, Roche-Campo F, Sferrazza Papa GF, Isabey D, Brochard L, Apiou-Sbirlea G (2013) Aerosol therapy during mechanical ventilation: an international survey. Intensive Care Med 39:1048\u20131056","journal-title":"Intensive Care Med"},{"key":"3376_CR15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(12)70322-5","volume":"13","author":"N Daneman","year":"2013","unstructured":"Daneman N, Sarwar S, Fowler RA, Cuthbertson BH (2013) Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 13:328\u2013341","journal-title":"Lancet Infect Dis"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-014-3376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-014-3376-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-014-3376-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:56:04Z","timestamp":1558616164000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-014-3376-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1007\/s00134-014-3376-7","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]}}}